VKH
REGN icon

Virtu KCG Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Virtu KCG Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,400
Closed -$4.56M – 3506
2015
Q4 		$4.56M Sell
8,400
-1,500
-15% -$813K 0.08% 161
2015
Q3 		$4.61M Buy
9,900
+7,900
+395% +$4.24M 0.08% 153
2015
Q2 		$1.02M Sell
2,000
-1,400
-41% -$683K 0.02% 822
2015
Q1 		$1.53M Sell
3,400
-7,700
-69% -$3.26M 0.03% 499
2014
Q4 		$4.55M Buy
11,100
+5,800
+109% +$2.28M 0.07% 167
2014
Q3 		$1.91M Sell
5,300
-5,300
-50% -$1.78M 0.04% 499
2014
Q2 		$2.99M Sell
10,600
-9,500
-47% -$2.82M 0.05% 334
2014
Q1 		$6.04M Buy
20,100
+900
+5% +$277K 0.08% 208
2013
Q4 		$5.29M Sell
19,200
-8,200
-30% -$2.36M 0.06% 220
2013
Q3 		$8.57M Buy
+27,400
New +$7.21M 0.11% 119

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Virtu KCG Holdings's REGN Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2017: 420 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #2138 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in REGN as recently as Q4 2016.

Virtu KCG Holdings first reported a position in REGN in Q3 2013 and has held it in 14 quarters since. The position peaked at $4.88M in Q1 2014. 604 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

  • Virtu KCG Holdings held 420 shares of Regeneron Pharmaceuticals worth $206K as of Q2 2017.
  • Regeneron Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Regeneron Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2138 holding.
  • Virtu KCG Holdings first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's Regeneron Pharmaceuticals position peaked at $4.88M in Q1 2014.
  • 604 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.